U italijanskom naučnom časopisu Epidemiology, Biostatistics and Public Health objavljena studija o efikasnosti preparata Bulardi

U italijanskom naučnom časopisu Epidemiology, Biostatistics and Public Health objavljena studija koja je posmatrala efikasnost preparata Bulardi.Ova vest je posebno važna s obzirom da je ovo prva objavljena studija koja je posmatrala efikasnost probiotske kulture Saccharomyces boulardii u našoj zemlji. U zaključku studije navodi se da primena probiotika Bulardi, Abela Pharm, sprečava nastanak antibiotskih dijareja kod hospitalizovanih pacijenata.

Naziv studije je Prophylactic use of Saccharomyces boulardii probiotics in preventing antibiotic-associated diarrhea: a single center hospital-based case-control study in Serbia.

Praćenje je izvedeno u Kliničkom centru Dr Dragiša Mišović-Dedinje, a autori studije su: Nikola Panić MD, Maja Tufegdžić MD, Stefania Boccia PhD, Marija Stokić, Milutin Bulajić PhD.

We use cookies to improve your experience. By clicking “I Agree”, you accept our privacy policy. You can read more in our cookie notice More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close